TSO3 Inc. (TSE:TOS) – Investment analysts at National Bank Financial dropped their FY2018 earnings estimates for shares of TSO3 in a report released on Sunday. National Bank Financial analyst E. Leno now expects that the company will earn $0.01 per share for the year, down from their prior forecast of $0.03.

Separately, Desjardins restated a “buy” rating and set a C$4.00 price objective on shares of TSO3 in a research report on Wednesday, October 18th.

TRADEMARK VIOLATION NOTICE: “TSO3 Inc. (TOS) Forecasted to Earn FY2018 Earnings of $0.01 Per Share” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/11/07/tso3-inc-tos-forecasted-to-earn-fy2018-earnings-of-0-01-per-share.html.

Shares of TSO3 (TSE:TOS) traded down C$0.08 on Tuesday, reaching C$2.67. The company had a trading volume of 138,304 shares, compared to its average volume of 78,852. TSO3 has a 52 week low of C$2.05 and a 52 week high of C$3.36.

In related news, Director Richard Mark Rumble acquired 22,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was purchased at an average cost of C$2.23 per share, for a total transaction of C$49,060.00.

TSO3 Company Profile

TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.

Earnings History and Estimates for TSO3 (TSE:TOS)

Receive News & Stock Ratings for TSO3 Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 Inc. and related stocks with our FREE daily email newsletter.